Collectively, our in vivo and in vitro results unequivocally demonstrated that inhibition of GHSR mitigates neuroinflammation under obesity, likely by reprogramming the AMPK-autophagy axis in neurons. The gene discussed is PRKAA2; the disease is obesity disorder.